How Kawasaki Disease Causes Coronary Artery Aneurysms
Kawasaki disease causes coronary artery aneurysms through aggressive neutrophil-mediated panmural vascular necrosis of the coronary arterial wall, followed by intimal hyperplasia and subacute lymphocytic inflammation, which weakens the vessel wall structure and leads to aneurysmal dilation. 1
Pathophysiologic Mechanism
The process unfolds in distinct phases:
Acute Inflammatory Phase
- Neutrophil-mediated destruction: The initial insult involves aggressive neutrophil infiltration causing panmural (full-thickness) vascular necrosis without granuloma formation 1
- This inflammatory assault destroys the structural integrity of all three layers of the coronary arterial wall
- The medium-caliber coronary arteries are preferentially targeted, though other medium vessels throughout the body can be affected 1
Subacute Remodeling Phase
- Following the acute neutrophilic phase, intimal hyperplasia develops with subacute lymphocytic inflammation 1
- CD8+ T cells contribute significantly to the ongoing inflammatory process within the arterial wall 2
- The NFAT-calcineurin calcium signaling pathway is activated, which genetic studies have linked to both disease susceptibility and aneurysm formation 2
Mechanical Factors
- Reduced shear stress at coronary branching sites promotes aneurysm formation—90.3% of aneurysms occur at major left coronary branching sites 3
- Disturbed flow patterns within developing aneurysms further propagate vessel wall damage and increase thrombosis risk 3
- The combination of weakened vessel walls from inflammation and altered hemodynamics leads to progressive dilation
Clinical Implications and Risk Stratification
Without treatment, 25% of patients develop coronary artery aneurysms; with appropriate IVIG therapy within 10 days, this drops to 5%. 1 However, critical exceptions exist:
- Infants under 6 months have a 50% aneurysm risk even with timely IVIG treatment 1
- IVIG-resistant patients face substantially higher risk of coronary complications 2
Progressive Vascular Remodeling
The pathologic process doesn't necessarily end after the acute phase:
- Aneurysms may initially regress in size but can progress to obstructive lesions through myofibroblast proliferation and stenosis 4, 5
- Vascular growth factors drive ongoing remodeling, leading to progressive localized stenosis, extensive recanalizations, or development of collateral vessels 5
- Late aneurysm formation can occur as a delayed phenomenon after a long latent period, manifesting as new-onset pathology or expansion of previously stable aneurysms 6
Key Clinical Pitfall
The histopathologic similarity to polyarteritis nodosa explains why fatal fulminant cases were historically misclassified as "infantile polyarteritis nodosa" before KD was recognized as a distinct entity 1. This underscores the importance of recognizing KD's unique medium-vessel vasculitis pattern and treating aggressively to prevent the 0.08% case fatality rate and long-term cardiac sequelae 1.